郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Lipoic-based TRPA1/TRPV1 antagonist to treat orofacial pain.

期刊：ACS chemical neuroscience发表年份：2015作者：Roberta Gualdani; Stefania Ceruti; Giulia Magni; Davide Merli; Lorenzo Di Cesare Mannelli; Oscar Francesconi; Barbara Richichi; Giancarlo la Marca; Carla Ghelardini; Maria Rosa Moncelli; Cristina Nativi
阅读更多 →

药效评价Exposure to Δ9-Tetrahydrocannabinol Impairs the Differentiation of Human Monocyte-derived Dendritic Cells and their Capacity for T cell Activation.

期刊：Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology发表年份：2015作者：Michael D Roth; Julie T Castaneda; Sylvia M Kiertscher
阅读更多 →

药效评价Discovery of (R)-1-(3-((2-chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate (TD-5959, GSK961081, batefenterol): first-in-class dual ph

期刊：Journal of medicinal chemistry发表年份：2015作者：Adam D Hughes; Yan Chen; Sharath S Hegde; Jeffrey R Jasper; Sarah Jaw-Tsai; Tae-Weon Lee; Alexander McNamara; M Teresa Pulido-Rios; Tod Steinfeld; Mathai Mammen
阅读更多 →

药效评价Cell-based and virtual fragment screening for adrenergic α2C receptor agonists.

期刊：Bioorganic & medicinal chemistry发表年份：2015作者：Edit Szőllősi; Amrita Bobok; László Kiss; Márton Vass; Dalma Kurkó; Sándor Kolok; András Visegrády; György M Keserű
阅读更多 →